Spero Therapeutics, Inc. (29) | Intellectual Property (3)
Browse by Subcategory
Recent Contracts
-
License Agreement, dated June 30, 2021, by and between the Registrant and Pfizer Inc
(Filed With SEC on August 5, 2021)
-
Amended and Restated License Agreement, dated January 15, 2021, by and between the Registrant and Everest Medicines II Limited
(Filed With SEC on March 11, 2021)
-
License Agreement, dated January 4, 2019, by and between New Pharma License Holdings Limited and Everest Medicines II Limited
(Filed With SEC on March 14, 2019)